Literature DB >> 9362258

LPS induces late cardiac functional protection against ischemia independent of cardiac and circulating TNF-alpha.

X Meng1, L Ao, J M Brown, D R Meldrum, B C Sheridan, B S Cain, A Banerjee, A H Harken.   

Abstract

Lipopolysaccharide (LPS) and tumor necrosis factor (TNF)-alpha independently induce cardioprotection against ischemia in the rat at 24 h after administration, suggesting that endogenously synthesized TNF-alpha may play a role in LPS-induced protection. The purposes of this study were 1) to delineate the time course of LPS-induced cardiac functional protection against ischemia and its relation with myocardial and circulating TNF-alpha profile, 2) to examine whether prior protein synthesis inhibition abrogates the protection, and 3) to assess the effects of TNF-alpha inhibition and neutralization on the protection. Rats were treated with LPS (0.5 mg/kg i.p.). Cardiac functional resistance to normothermic global ischemia-reperfusion was examined at sequential time points after LPS treatment in isolated hearts by the Langendorff technique. Myocardial and circulating TNF-alpha was determined by enzyme-linked immunosorbent assay at 1-24 h after LPS treatment. Protection was apparent at 24 h, 3 days, and 7 days but not at 2 or 12 h. Maximal protection at 3 days was abolished by cycloheximide pretreatment (0.5 mg/kg i.p. 3 h before LPS treatment). Increases in myocardial and circulating TNF-alpha preceded the acquisition of protection. Dexamethasone pretreatment (4.0 or 8.0 mg/kg i.p. 30 min before LPS treatment) abolished peak increase in myocardial TNF-alpha and substantially suppressed circulating TNF-alpha (54.3 and 85.9% inhibition, respectively) without an influence on the maximal protection. Similarly, maximal protection was not affected by TNF binding protein (40 or 80 microg/kg i.v. immediately after LPS treatment). The results suggest that LPS-induced cardiac functional protection against ischemia is a delayed and long-lasting protective response that may involve de novo protein synthesis. Although LPS-induced increase in myocardial and circulating TNF-alpha precedes the delayed protection, it may not be required for the delayed protection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362258     DOI: 10.1152/ajpheart.1997.273.4.H1894

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Toll-like receptor 4 signaling confers cardiac protection against ischemic injury via inducible nitric oxide synthase- and soluble guanylate cyclase-dependent mechanisms.

Authors:  E Wang; Yan Feng; Ming Zhang; Lin Zou; Yan Li; Emmanuel S Buys; Peigen Huang; Peter Brouckaert; Wei Chao
Journal:  Anesthesiology       Date:  2011-03       Impact factor: 7.892

2.  Lipopolysaccharide pretreatment protects against ischemia/reperfusion injury via increase of HSP70 and inhibition of NF-κB.

Authors:  Yong-wei Yao; Guo-hui Zhang; Ying-yu Zhang; Wei-dong Li; Cheng-hua Wang; Chun-yang Yin; Fu-min Zhang
Journal:  Cell Stress Chaperones       Date:  2010-11-16       Impact factor: 3.667

3.  Delayed myocardial protection induced by endotoxin does not involve kinin B(1)-receptors.

Authors:  C Mazenot; F Gobeil; C Ribuot; D Regoli; D Godin-Ribuot
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

4.  Nitric oxide synthase-2 induction optimizes cardiac mitochondrial biogenesis after endotoxemia.

Authors:  Crystal M Reynolds; Hagir B Suliman; John W Hollingsworth; Karen E Welty-Wolf; Martha Sue Carraway; Claude A Piantadosi
Journal:  Free Radic Biol Med       Date:  2008-11-27       Impact factor: 7.376

5.  Toll-like receptor 4 is essential to preserving cardiac function and survival in low-grade polymicrobial sepsis.

Authors:  Ming Zhang; Lin Zou; Yan Feng; Yu-Jung Chen; Qichang Zhou; Fumito Ichinose; Wei Chao
Journal:  Anesthesiology       Date:  2014-12       Impact factor: 7.892

6.  Pharmacological postconditioning effect of muramyl dipeptide is mediated through RIP2 and TAK1.

Authors:  Pierre Sicard; Sebastien Jacquet; Koichi S Kobayashi; Richard A Flavell; Michael S Marber
Journal:  Cardiovasc Res       Date:  2009-02-12       Impact factor: 10.787

7.  The role of nitric oxide in endotoxin-induced cardiodepression.

Authors:  Alla G Portnychenko; Olga Yu Harmatina; Anatolij V Kotsuruba; Oleksij O Moybenko
Journal:  Exp Clin Cardiol       Date:  2005

8.  Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways.

Authors:  Jian-Wen Dong; Jesus G Vallejo; Huei-Ping Tzeng; James A Thomas; Douglas L Mann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-01-08       Impact factor: 4.733

Review 9.  Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart.

Authors:  Wei Chao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-11-14       Impact factor: 4.733

10.  Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice.

Authors:  Yan Feng; Huailong Zhao; Xinhua Xu; Emmanuel S Buys; Michael J Raher; Jean C Bopassa; Helene Thibault; Marielle Scherrer-Crosbie; Ulrich Schmidt; Wei Chao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-25       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.